Invivyd Inc.

10/19/2024 | Press release | Distributed by Public on 10/19/2024 08:18

Clinical Efficacy Endpoints from the Phase 3 CANOPY Study Evaluating Pemivibart for the Prevention of COVID-19Popejoy et al. IDWeek. 2024.